|
SMARCD2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.30080399177268E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.21460003060992E-09 |
| Normal-vs-Stage2 |
2.695300E-03 |
| Normal-vs-Stage3 |
1.376450E-03 |
| Normal-vs-Stage4 |
2.737600E-02 |
| Stage1-vs-Stage2 |
6.635400E-01 |
| Stage1-vs-Stage3 |
5.129800E-01 |
| Stage1-vs-Stage4 |
3.960000E-01 |
| Stage2-vs-Stage3 |
9.061200E-01 |
| Stage2-vs-Stage4 |
3.235000E-01 |
| Stage3-vs-Stage4 |
2.911000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62630020561494E-10 |
| Normal-vs-AfricanAmerican |
1.08910000018447E-07 |
| Normal-vs-Asian |
1.257370E-01 |
| Caucasian-vs-AfricanAmerican |
5.295200E-01 |
| Caucasian-vs-Asian |
7.036400E-01 |
| AfricanAmerican-vs-Asian |
6.639800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.22969975816056E-10 |
| Normal-vs-Female |
4.0315000005009E-08 |
| Male-vs-Female |
2.750400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.55669999999786E-05 |
| Normal-vs-Extreme_Weight |
2.17249999989733E-07 |
| Normal-vs-Obese |
6.84469999567838E-08 |
| Normal-vs-Extreme_Obese |
1.282220E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.465600E-01 |
| Normal_Weight-vs-Obese |
6.806800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.682800E-01 |
| Extreme_Weight-vs-Obese |
4.642800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.946200E-01 |
| Obese-vs-Extreme_Obese |
4.689000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.52589999996766E-06 |
| Normal-vs-Age(41-60Yrs) |
2.79649636780732E-11 |
| Normal-vs-Age(61-80Yrs) |
4.23520000181199E-08 |
| Normal-vs-Age(81-100Yrs) |
3.948800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.217530E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.722000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.611000E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.085200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.171800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.091390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.21884749357559E-14 |
| Normal-VS-Type2 PRCC |
8.572500E-02 |
| Normal-VS-KIRP CIMP |
4.35899999999823E-05 |
| Normal-VS-Unclassified PRCC |
1.612890E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.8961499037573E-12 |
| Type1 PRCC-VS-KIRP CIMP |
2.044100E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.529410E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.58889568169229E-11 |
| Type2 PRCC-VS-Unclassified PRCC |
4.043900E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.799200E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.011500E-04 |
| Normal-vs-N1 |
3.554900E-04 |
| Normal-vs-N2 |
1.526030E-01 |
| N0-vs-N1 |
3.674400E-02 |
| N0-vs-N2 |
7.970000E-02 |
| N1-vs-N2 |
8.299200E-01 |
|
|
